CICLOPIROX Drug Patent Profile
✉ Email this page to a colleague
When do Ciclopirox patents expire, and when can generic versions of Ciclopirox launch?
Ciclopirox is a drug marketed by Cosette, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Alvogen, Glenmark Pharms Inc, Padagis Us, Actavis Mid Atlantic, Encube, Acella, Chartwell Rx, Epic Pharma Llc, Hikma, Mylan Pharms Inc, Rising, Taro Pharm Inds, and Teva Pharms. and is included in twenty-eight NDAs.
The generic ingredient in CICLOPIROX is ciclopirox. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciclopirox
A generic version of CICLOPIROX was approved as ciclopirox by FOUGERA PHARMS on August 6th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CICLOPIROX?
- What are the global sales for CICLOPIROX?
- What is Average Wholesale Price for CICLOPIROX?
Summary for CICLOPIROX
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 28 |
Finished Product Suppliers / Packagers: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 107 |
Clinical Trials: | 13 |
Patent Applications: | 5,211 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CICLOPIROX |
Drug Sales Revenues: | Drug sales revenues for CICLOPIROX |
What excipients (inactive ingredients) are in CICLOPIROX? | CICLOPIROX excipients list |
DailyMed Link: | CICLOPIROX at DailyMed |
![CICLOPIROX drug patent expirations Drug patent expirations by year for CICLOPIROX](/p/graph/s/t/CICLOPIROX-patent-expirations.png)
![Drug Prices for CICLOPIROX](/p/graph/drug-price/CICLOPIROX.png)
See drug prices for CICLOPIROX
![Drug Sales Revenue Trends for CICLOPIROX](/p/graph/drug-sales-revenues/CICLOPIROX.png)
Recent Clinical Trials for CICLOPIROX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universidad Complutense de Madrid | Phase 4 |
Atlas Molecular Pharma | Phase 1 |
BCDiabetes.Ca | N/A |
Pharmacology for CICLOPIROX
Mechanism of Action | Protein Synthesis Inhibitors |
Physiological Effect | Decreased DNA Replication Decreased Protein Synthesis Decreased RNA Replication |
Anatomical Therapeutic Chemical (ATC) Classes for CICLOPIROX
Paragraph IV (Patent) Challenges for CICLOPIROX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CICLOPIROX | Gel | ciclopirox | 0.77% | 020519 | 1 | 2006-05-10 |
US Patents and Regulatory Information for CICLOPIROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | CICLOPIROX | ciclopirox | SUSPENSION;TOPICAL | 077092-001 | Aug 10, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cosette | CICLOPIROX | ciclopirox | CREAM;TOPICAL | 078463-001 | Dec 20, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Encube | CICLOPIROX | ciclopirox | SOLUTION;TOPICAL | 077687-001 | Sep 18, 2007 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Taro Pharm Inds | CICLOPIROX | ciclopirox | SOLUTION;TOPICAL | 078144-001 | Sep 18, 2007 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fougera Pharms | CICLOPIROX | ciclopirox | GEL;TOPICAL | 077896-001 | Jun 10, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Padagis Israel | CICLOPIROX | ciclopirox | CREAM;TOPICAL | 077364-001 | Mar 3, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CICLOPIROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CICLOPIROX
See the table below for patents covering CICLOPIROX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 216882 | ⤷ Sign Up | |
Norway | 321899 | ⤷ Sign Up | |
Malaysia | 117863 | ANTIMYCOTIC AGENTS HAVING HIGH ACTIVE COMPOUND RELEASE | ⤷ Sign Up |
China | 1231609 | ⤷ Sign Up | |
European Patent Office | 0928192 | GEL ANTIMYCOTIQUE A FORTE LIBERATION DE PRINCIPE ACTIF (ANTIMYCOTIC GEL WITH HIGH ACTIVE SUBSTANCE RELEASE) | ⤷ Sign Up |
Yugoslavia | 13599 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |